Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants
- 1 October 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (10) , 931-940
- https://doi.org/10.1097/00006454-200110000-00005
Abstract
Immunization of healthy women before pregnancy is a potential approach to providing increased levels of maternal antibody to newborns to protect them from infections occurring during the perinatal period and first months of life. Healthy nonpregnant Pima Indian women of childbearing age were randomized to receive one of two Haemophilus influenzae type b (Hib) conjugate vaccines [HbOC or Hib-meningococcal outer membrane protein complex (OMP)] or a 23-valent pneumococcal polysaccharide vaccine (PnPs). Infants received Hib-OMP vaccine at 2, 4 and 12 months of age. Vaccine safety and immunogenicity was evaluated in the women and their infants. Anti-polyribose ribitol phosphate antibody titers were significantly higher in women in both Hib conjugate vaccine groups than in the pneumococcal vaccine group throughout the 37-month observation period. Antibody responses to HbOC vaccine were significantly higher than those to Hib-OMP. A subsequent booster dose of each Hib conjugate vaccine induced reactions and antibody responses similar to those of the first dose. Infants born to mothers immunized with Hib vaccines compared with PnPs had significantly higher polyribose ribitol phosphate-specific IgG antibody titers at birth and 2 months of age but lower antibody responses to Hib-OMP at 6 months and similar titers before and after boosting with Hib-OMP at 1 year of age. By contrast women immunized with PnPs did not have significantly elevated concentrations of pneumococcal-specific antibody at delivery, and their infants had pneumococcal antibody titers similar to those of infants born to mothers who did not receive pneumococcal vaccine before pregnancy. Hib conjugate vaccine given to women before pregnancy significantly increased the proportion of infants who had protective Hib antibody levels at birth and 2 months of age.Keywords
This publication has 18 references indexed in Scilit:
- Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter studyThe Pediatric Infectious Disease Journal, 1999
- Transplacental Antibody Transfer Following Maternal Immunization With Polysaccharide And Conjugate Haemophilus influenzae Type B VaccinesThe Journal of Infectious Diseases, 1995
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- Impaired Antibody Response toHaemophilus influenzaeType b Polysaccharide and Low IgG2 and IgG4 Concentrations in Apache ChildrenNew England Journal of Medicine, 1990
- Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugateThe Journal of Pediatrics, 1989
- Concentrations of antibodies in paired maternal and infant sera: Relationship to IgG subclassThe Journal of Pediatrics, 1987
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in adultsThe Journal of Pediatrics, 1984
- The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type bThe Journal of Infectious Diseases, 1983